Review: could Methotrexate cause Venoocclusive Liver Disease?


Summary

Venoocclusive liver disease is found among people who take Methotrexate, especially for people who are male, 2-9 old , have been taking the drug for < 1 month, also take medication Cyclosporine, and have Stem cell transplant . We study 128,586 people who have side effects while taking Methotrexate from FDA and social media. Among them, 336 have Venoocclusive liver disease. Find out below who they are, when they have Venoocclusive liver disease and more.

You are not alone

Join a support group for people who take Methotrexate and have Venoocclusive liver disease >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Methotrexate

It is often used in rheumatoid arthritis. (latest outcomes from Methotrexate 129,243 users)

Venoocclusive Liver Disease

Venoocclusive liver disease (small veins in the liver are obstructed) has been reported by people with multi-organ failure, disseminated intravascular coagulation, sinusitis, pneumonia, rhabdomyosarcoma (latest reports from 1,551 Venoocclusive liver disease patients).

On Jul, 23, 2016

128,586 people reported to have side effects when taking Methotrexate.
Among them, 336 people (0.26%) have Venoocclusive Liver Disease


Number of reports submitted per year:

Could Methotrexate cause Venoocclusive liver disease?

Time on Methotrexate when people have Venoocclusive Liver Disease *:

  • < 1 month: 92.68 %
  • 1 - 6 months: 3.66 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 3.66 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Venoocclusive Liver Disease when taking Methotrexate *:

  • female: 43.45 %
  • male: 56.55 %

Age of people who have Venoocclusive Liver Disease when taking Methotrexate *:

  • 0-1: 6.1 %
  • 2-9: 23.98 %
  • 10-19: 14.23 %
  • 20-29: 15.04 %
  • 30-39: 4.47 %
  • 40-49: 11.38 %
  • 50-59: 19.92 %
  • 60+: 4.88 %

Top conditions involved for these people *:

  • Stem Cell Transplant (69 people)
  • Graft Versus Host Disease (45 people)
  • Bone Marrow Transplant (38 people)
  • Bone Marrow Conditioning Regimen (31 people)
  • Prophylaxis (24 people)

Top co-used drugs for these people *:

  • Cyclosporine (112 people)
  • Cyclophosphamide (109 people)
  • Tacrolimus (78 people)
  • Prograf (60 people)
  • Acyclovir (41 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Venoocclusive liver disease when taking Methotrexate?

Browse all side effects of Methotrexate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Venoocclusive liver disease

Venoocclusive liver disease

Could your condition cause Venoocclusive liver disease

Venoocclusive liver disease

Can you answer these questions?

More questions for: Methotrexate, Venoocclusive liver disease

You may be interested in these reviews

More reviews for: Methotrexate, Venoocclusive liver disease


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.